Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Plos One
|
August 7, 2009
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy
George J Cerniglia, Nabendu Pore, Jeff H Tsai, et al.
Cancer
|
May 1, 2021
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
Arlene E Garcia-Soto, Nathalie D McKenzie, Margaret E Whicker, et al.
Frontiers in Oncology
|
December 15, 2022
A phenomenological model of proton FLASH oxygen depletion effects depending on tissue vasculature and oxygen supply
Wei Zou, Haram Kim, Eric S Diffenderfer, et al.
JAMA Oncology
|
August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial
Ramesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Cancer Research
|
August 14, 2023
Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
Renzo Perales-Linares, Nektaria Maria Leli, Hesham Mohei, et al.
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
Shwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
Clinical and Translational Radiation Oncology
|
January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy
Nikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy
Jahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 14, 2020
Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System
Eric S Diffenderfer, Ioannis I Verginadis, Michele M Kim, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Plos One
|
August 7, 2009
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy
George J Cerniglia, Nabendu Pore, Jeff H Tsai, et al.
Cancer
|
May 1, 2021
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
Arlene E Garcia-Soto, Nathalie D McKenzie, Margaret E Whicker, et al.
Frontiers in Oncology
|
December 15, 2022
A phenomenological model of proton FLASH oxygen depletion effects depending on tissue vasculature and oxygen supply
Wei Zou, Haram Kim, Eric S Diffenderfer, et al.
JAMA Oncology
|
August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial
Ramesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Cancer Research
|
August 14, 2023
Parkin Deficiency Suppresses Antigen Presentation to Promote Tumor Immune Evasion and Immunotherapy Resistance
Renzo Perales-Linares, Nektaria Maria Leli, Hesham Mohei, et al.
Cancer Immunology Research
|
June 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells
Shujing Liu, Alain H Rook, Alexander C Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
Shwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
Clinical and Translational Radiation Oncology
|
January 31, 2023
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy
Nikhil Yegya-Raman, Christopher M Wright, Michael J LaRiviere, et al.
Journal of the National Cancer Institute
|
April 16, 2020
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy
Jahan J Mohiuddin, Brian Chu, Andrea Facciabene, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 14, 2020
Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System
Eric S Diffenderfer, Ioannis I Verginadis, Michele M Kim, et al.
Page
of 12